Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Bringing Kashmir’s lakes back to life 25 min · 23 Sep 2026 · The Documentary Podcast

Soup 56 min · 23 Sep 2026 · Three Bean Salad

AFL Record Editor Ash Browne | Grand Final edition on sale now! (23.09.26) 2 min · 23 Sep 2026 · Whateley

NPR News: 09-22-2026 8PM EDT 4 min · 23 Sep 2026 · NPR News Now

Send Me To Sleep | Aristotle 44 min · 23 Sep 2026 · Send Me To Sleep

Finding the balance between offence & defence | The Art of Coaching with Ken Hinkley! (23.09.26) 5 min · 23 Sep 2026 · Whateley

Report any issue

Source

Recorded28 Mar 2024

Publisherneurology.libsyn.com ↗

Handlerec:5447480

Show notes

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation. Disclosures can be found at Neurology.org.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in